Paul J. Isaac Purchases 23,299 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXSGet Free Report) Director Paul J. Isaac bought 23,299 shares of the company’s stock in a transaction on Thursday, March 6th. The shares were bought at an average price of $1.81 per share, with a total value of $42,171.19. Following the completion of the transaction, the director now owns 49,066 shares of the company’s stock, valued at $88,809.46. The trade was a 90.42 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Stereotaxis Price Performance

STXS stock traded down $0.08 during mid-day trading on Monday, hitting $1.80. 206,459 shares of the stock were exchanged, compared to its average volume of 448,136. The company has a market cap of $152.09 million, a PE ratio of -6.41 and a beta of 1.54. The firm’s fifty day simple moving average is $2.27. Stereotaxis, Inc. has a 12 month low of $1.66 and a 12 month high of $3.29.

Institutional Trading of Stereotaxis

A number of hedge funds have recently bought and sold shares of the company. ProShare Advisors LLC grew its stake in shares of Stereotaxis by 53.6% during the fourth quarter. ProShare Advisors LLC now owns 15,913 shares of the company’s stock valued at $36,000 after buying an additional 5,556 shares during the last quarter. Two Sigma Securities LLC purchased a new stake in Stereotaxis during the 4th quarter valued at about $54,000. SG Americas Securities LLC grew its position in Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after acquiring an additional 7,417 shares during the last quarter. Jane Street Group LLC increased its stake in Stereotaxis by 26.9% in the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after purchasing an additional 6,313 shares during the period. Finally, Wells Fargo & Company MN lifted its position in Stereotaxis by 53.7% in the fourth quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock valued at $61,000 after purchasing an additional 9,403 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

About Stereotaxis

(Get Free Report)

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

Featured Stories

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.